Skip to content

CorMedix CRMD Preferred Stock, Shares Issued

Preferred Stock, Shares Issued at other companies

Emergent Biosolutions logo
Emergent BiosolutionsEBS
Abbott logo
AbbottABT
ICU Medical logo
ICU MedicalICUI
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
Medline, Inc.
 logo
Medline, Inc. MDLN
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesIssued.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's preferred stock, shares issued.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's preferred stock, shares issued?
CorMedix (CRMD) reported preferred stock, shares issued of $91.62K in Q1 2026.
How has CorMedix's preferred stock, shares issued changed year-over-year?
CorMedix's preferred stock, shares issued decreased by 0.0% year-over-year, from $91.62K to $91.62K.
What is the long-term trend for CorMedix's preferred stock, shares issued?
Over 5 years (2020 to 2025), CorMedix's preferred stock, shares issued has grown at a -17.6% compound annual growth rate (CAGR), from $241.62K to $91.62K.